Navigation Links
John McEnroe is Serious About Getting Men to Take the '50 Over 50 Prostate Health Challenge'
Date:3/16/2009

PHILADELPHIA, March 16 /PRNewswire/ -- Three-time Wimbledon and four-time US Open Champion John McEnroe has teamed up with GlaxoSmithKline (NYSE: GSK) to create a public-education initiative entitled the "50 Over 50 Prostate Health Challenge."

Fifty percent of men over 50 years of age have an enlarging prostate; if left untreated it can lead to worsening urinary symptoms and even prostate-related surgery.

"I just celebrated my 50th birthday, and while I'm still as active as ever, I know there are certain health issues I need to stay on top of, including my prostate health," said McEnroe. "Now I'm asking other men to take the '50 Over 50 Prostate Health Challenge.' It's all about talking to your doctor and getting serious about your prostate health."

As a part of the campaign, an interactive web site, www.50over50challenge.com, has been created where men can start the "Prostate Health Challenge." The challenge is to take three easy steps to get serious about prostate health: a brief online prostate health assessment; seeing a doctor for a prostate-health exam; and knowing your PSA (Prostate-specific antigen) level. PSA level, obtained from a simple blood test, is a protein marker that can rise when a prostate condition is present.

McEnroe will also be featured in public education video messages that will appear throughout the year on network television, internet sites and at 50over50challenge.com. The first video vignette will air on April 4 in between the first and second games of the men's college basketball semi final on CBS. There will also be national print messages in March and April running in such publications as USA Today, Sports Illustrated, Time and Newsweek.

"Prostate health can be awkward to talk about, so we've created a series of hopefully memorable, vignettes to help get men talking. I am hoping my involvement will be motivational and encourage men to take the Challenge and take control of their prostate health," added McEnroe.

About Enlarging Prostate

Enlarging prostate is a prevalent and progressive condition that affects approximately 50 percent of men over 50 years of age and over 90 percent of men older than age 80. An enlarged prostate can cause changes in urinary habits because of its location around the urethra. Over time, the prostate can continue to grow and urinary symptoms may worsen as the bladder loses the ability to empty itself. Left untreated, in severe cases, an enlarged prostate can lead to serious long-term problems including acute urinary retention (AUR) and the need for prostate-related surgery.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008
2. Local Communities Get Serious About Saving Lives Through Project Lifesaver Tracking Equipment, Says NAA
3. New Texas Study Reveals Serious Flaws in Abstinence Programs
4. Harmonix Music Systems, Inc. and MTV Games Make a Donation to Starlight and Bring Rock Band(R) to Thousands of Seriously Ill Children
5. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
6. Sexual health promotion is low among people with serious mental illnesses, despite higher risk
7. Pharmaceuticals sold in Sweden cause serious environmental harm in India
8. Physical activity, mood and serious mental illness
9. AFB Survey Finds Drug Labeling Puts People with Vision Loss at Serious Medical Risk
10. Late preterm births present serious risks to newborns
11. Americans Want Schools to Take Recess Seriously
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... and HR decision-makers are preparing for how his administration could impact the employee ... insight into what changes are most likely to make it through Congress. His ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would ... results in a fraction of the time as traditional braces – Wilckodontics®. Dr. ... Specialists, now offers this revolutionary treatment with or without a referral. , ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place ... to a special report in the May issue of Consumer Reports focused on heart ... ranking for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: